Evaluation of Extended Interval Dosing Aminoglycosides in the Morbidly Obese Population

Table 1

Patient demographics.

Patient-specific parameters (𝑛=31)
Patients receiving gentamicin	52%
Gender	68% females
Mean age	51 years ± 13.3
Mean weight	127.7 kg ± 24.5
Mean weight above IBW	212% ± 24.7
Mean aminoglycoside dosing	5.9 mg/kg ± 0.9
Mean serum creatinine	0.86 mg/dL ± 0.2
Mean CrCl	132.3 mL/min ± 43.2